Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Oaktree Acquisition Corp. III Life Sciences Class A ( (OACC) ) has provided an update.
On June 3, 2025, Courtney Conigliaro resigned as CFO of Oaktree Acquisition Corp. III Life Sciences to pursue other opportunities, with no disagreements cited. Thomas Sweeney, a Managing Director at Oaktree Capital Management, was appointed as the new CFO, bringing extensive experience in accounting and finance, but will not receive compensation for his role.
More about Oaktree Acquisition Corp. III Life Sciences Class A
Oaktree Acquisition Corp. III Life Sciences operates within the life sciences industry, focusing on acquisitions and investments in the sector. The company is part of Oaktree Capital Management, which specializes in private credit strategies and business development companies.
Average Trading Volume: 114,852
Find detailed analytics on OACC stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue